188
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluations

Besifloxacin, a new ophthalmic fluoroquinolone for the treatment of bacterial conjunctivitis

, PharmD & , PhD
Pages 2545-2554 | Published online: 10 Sep 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jason A Wiles, Barton J Bradbury & Michael J Pucci. (2010) New quinolone antibiotics: a survey of the literature from 2005 to 2010. Expert Opinion on Therapeutic Patents 20:10, pages 1295-1319.
Read now

Articles from other publishers (12)

Prashant Garg, Umang Mathur, Parul Sony, Radhika Tandon, Timothy W. Morris & Timothy L. Comstock. (2017) Clinical and Antibacterial Efficacy and Safety of Besifloxacin Ophthalmic Suspension Compared With Moxifloxacin Ophthalmic Solution. Asia-Pacific Journal of Ophthalmology, pages 1-6.
Crossref
Xianyong Yu, Bingfei Jiang, Zhixi Liao, Yue Jiao & Pinggui Yi. (2015) Study on the interaction between Besifloxacin and bovine serum albumin by spectroscopic techniques. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 149, pages 116-121.
Crossref
Jiang Wang, María Sánchez-Roselló, José Luis Aceña, Carlos del Pozo, Alexander E. Sorochinsky, Santos Fustero, Vadim A. Soloshonok & Hong Liu. (2013) Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011). Chemical Reviews 114:4, pages 2432-2506.
Crossref
Jonathan H. Talamo, Kathryn M. Hatch & Emily C. Woodcock. (2013) Delayed Epithelial Closure After PRK Associated With Topical Besifloxacin Use. Cornea 32:10, pages 1365-1368.
Crossref
Wolfgang Haas, Lynne S. Gearinger, Christine K. Hesje, Christine M. Sanfilippo & Timothy W. Morris. (2012) Microbiological Etiology and Susceptibility of Bacterial Conjunctivitis Isolates from Clinical Trials with Ophthalmic, Twice-Daily Besifloxacin. Advances in Therapy 29:5, pages 442-455.
Crossref
. (2012) Antibiotics - (Vol. 16, No. 2, Full Issue). Asia-Pacific Biotech News 16:02.
Crossref
. (2012) FEATURES. Asia-Pacific Biotech News 16:02, pages 15-33.
Crossref
Jose Benitez-del-Castillo, Yves Verboven, David Stroman & Laurent Kodjikian. (2011) The Role of Topical Moxifloxacin, a New Antibacterial in Europe, in the Treatment of Bacterial Conjunctivitis. Clinical Drug Investigation 31:8, pages 543-557.
Crossref
Kevin K.-C. Liu, Subas M. Sakya, Christopher J. O’Donnell, Andrew C. Flick & Jin Li. (2011) Synthetic approaches to the 2009 new drugs. Bioorganic & Medicinal Chemistry 19:3, pages 1136-1154.
Crossref
Erin W. NorcrossMelissa E. SandersQuincy MooreIIIIIIChristine M. SanfilippoChristine K. HesjeAfshin ShafieeMary E. Marquart. (2010) Comparative Efficacy of Besifloxacin and Other Fluoroquinolones in a Prophylaxis Model of Penicillin-Resistant Streptococcus pneumoniae Rabbit Endophthalmitis . Journal of Ocular Pharmacology and Therapeutics 26:3, pages 237-243.
Crossref
Jin-Zhong Zhang, Kathleen L. Krenzer, Francisco J. López & Keith W. Ward. (2010) Comparative effects of besifloxacin and other fluoroquinolones on corneal reepithelialization in the rabbit. Journal of Cataract and Refractive Surgery 36:6, pages 1049-1050.
Crossref
Shridhar Hegde & Michelle Schmidt. 2010. 466 537 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.